Value dossier and health economic model for a provider of haemodialysis

Cases 6 Oct 2022 Bert Vrijhoef |

A large provider of haemodialysis services wanted to increase the market share of one of their products. They requested Panaxea 1) to develop a health economic value story to secure global reimbursement for this technology; 2) and to develop a model incorporating both a cost-effectiveness and budget impact analysis to support this dossier.

Markov model

A value story concerning the effectiveness of both treatment modalities was written following an extensive literature review. Based on this we developed a Markov model to project costs, reimbursement and adverse events over a time horizon of five years. The model allows all input parameters to be changed, to make the model match closely to the decision makers population characteristics, reimbursement and cost patterns.

Let us help you in making your innovation count.